Strs Ohio Has $5.76 Million Position in Hill-Rom Holdings, Inc. (NYSE:HRC)

Strs Ohio lessened its holdings in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 65,011 shares of the medical technology company’s stock after selling 1,462 shares during the period. Strs Ohio owned approximately 0.10% of Hill-Rom worth $5,756,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of HRC. Raymond James & Associates increased its position in Hill-Rom by 28.1% during the 2nd quarter. Raymond James & Associates now owns 7,869 shares of the medical technology company’s stock valued at $687,000 after purchasing an additional 1,728 shares during the period. California Public Employees Retirement System grew its holdings in shares of Hill-Rom by 3.2% during the 2nd quarter. California Public Employees Retirement System now owns 177,972 shares of the medical technology company’s stock worth $15,544,000 after purchasing an additional 5,501 shares during the period. Advisors Asset Management Inc. lifted its stake in Hill-Rom by 5,508.5% during the 2nd quarter. Advisors Asset Management Inc. now owns 57,543 shares of the medical technology company’s stock worth $589,000 after acquiring an additional 56,517 shares in the last quarter. United Services Automobile Association raised its position in Hill-Rom by 7.7% in the 2nd quarter. United Services Automobile Association now owns 21,534 shares of the medical technology company’s stock valued at $1,881,000 after purchasing an additional 1,544 shares in the last quarter. Finally, CHURCHILL MANAGEMENT Corp grew its stake in Hill-Rom by 5.4% during the 3rd quarter. CHURCHILL MANAGEMENT Corp now owns 53,008 shares of the medical technology company’s stock worth $5,004,000 after buying an additional 2,710 shares during the last quarter. Institutional investors and hedge funds own 86.96% of the company’s stock.

In related news, SVP Andreas G. Frank sold 7,454 shares of the company’s stock in a transaction dated Wednesday, November 28th. The shares were sold at an average price of $95.76, for a total value of $713,795.04. Following the transaction, the senior vice president now owns 27,224 shares in the company, valued at approximately $2,606,970.24. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.73% of the company’s stock.

HRC opened at $103.50 on Thursday. Hill-Rom Holdings, Inc. has a 12-month low of $79.36 and a 12-month high of $105.78. The stock has a market cap of $6.84 billion, a P/E ratio of 21.79, a PEG ratio of 1.45 and a beta of 0.95. The company has a current ratio of 1.70, a quick ratio of 1.25 and a debt-to-equity ratio of 1.17.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, January 25th. The medical technology company reported $1.02 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.98 by $0.04. The firm had revenue of $683.50 million for the quarter, compared to analysts’ expectations of $676.39 million. Hill-Rom had a return on equity of 21.23% and a net margin of 7.21%. Hill-Rom’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.92 earnings per share. Equities analysts forecast that Hill-Rom Holdings, Inc. will post 5.06 earnings per share for the current year.

A number of equities research analysts have issued reports on HRC shares. Zacks Investment Research downgraded Hill-Rom from a “buy” rating to a “hold” rating in a research report on Wednesday, November 14th. Morgan Stanley reduced their target price on shares of Hill-Rom from $100.00 to $98.00 and set an “equal weight” rating for the company in a research note on Wednesday, January 2nd. Finally, ValuEngine lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a report on Wednesday, January 2nd. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $102.67.

COPYRIGHT VIOLATION WARNING: This piece was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.baseballdailydigest.com/news/2019/02/14/strs-ohio-has-5-76-million-stake-in-hill-rom-holdings-inc-hrc.html.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

See Also: Roth IRA

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply